NEURONETICS, INC. (STIM) Return on equity 2018–2025
NEURONETICS, INC. (STIM) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-174.3%FY2025 · since FY2018: -33.9% → -174.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -174.3% | -16.5 pp |
| FY2024 | -157.8% | -69.5 pp |
| FY2023 | -88.3% | -23.2 pp |
| FY2022 | -65.1% | -28.5 pp |
| FY2021 | -36.6% | +71.1 pp |
| FY2020 | -107.7% | -47.0 pp |
| FY2019 | -60.7% | -26.8 pp |
| FY2018 | -33.9% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice